SOP for Country Registration Document Collection and Verification


Regulatory Affairs: SOP for Country Registration Document Collection and Verification – V 1.0

Standard Operating Procedure for Country Registration Document Collection and Verification

Department Regulatory Affairs
SOP No. RA/2026/645
Supersedes NA
Page No. 1 of X
Issue Date 09/04/2026
Effective Date 09/04/2026
Review Date 09/04/2028

Purpose

This Standard Operating Procedure (SOP) defines the systematic process for the collection, verification, and management of country registration documents to ensure regulatory compliance and maintain integrity of submission dossiers. The objective is to facilitate controlled and accurate documentation flow, support timely product registration, and meet regulatory agency requirements effectively.

Scope

This SOP applies to all activities related to the collection, verification, and filing of registration documents for pharmaceutical products, medical devices, or related submissions across all countries in which the organization intends to market its products. It covers documents received from internal departments, external agencies, and regulatory bodies. This procedure excludes documents unrelated to product registration or market entry processes.

Responsibilities

  • Regulatory Affairs Officers: Collect and verify completeness and accuracy of registration documents.
  • Regulatory Supervisors: Review and supervise document verification activities.
  • Quality Assurance: Verify compliance and audit trail of document handling.
  • Documentation Control: Maintain controlled records and ensure proper filing and retrieval.
  • Regulatory Managers: Oversee process adherence and approve key submission documents.
See also  SOP for Line Extension Evaluation and Regulatory Filing

Accountability

The Regulatory Affairs Head is accountable for the implementation, compliance, regular review, escalation of issues, and periodic evaluation of the effectiveness of this SOP. They ensure all regulatory document collection and verification activities align with applicable regulations and internal quality standards.

Procedure

1. Preparation

Before initiating the document collection, ensure the scope of submission is identified, and communication channels with internal and external stakeholders are established. Verify the country-specific regulatory checklist to identify required documents.

2. Collection of Documents

Request and obtain registration documents such as registration certificates, dossiers, stability data, certifications, and correspondence from responsible departments or regulatory authorities. Ensure documents are received via authorized formats and channels.

3. Verification and Completeness Check

Review all collected documents for completeness, legibility, version control, and alignment with the regulatory requirements specific to the target country. Verify critical attributes such as signatures, dates, and official stamps. Record any discrepancies or missing information.

4. Quality and Compliance Checks

Cross-check documents against approved templates and regulatory standards. Conduct GMP and quality system compliance verification where applicable. Identify deviations and raise queries for resolution before acceptance.

5. Approvals and Documentation

Submit the verified documents to Regulatory Supervisors or Managers for review and approval. Ensure all confirmations and approvals are documented in the document tracking system.

6. Record Retention and Filing

Store accepted documents in a controlled environment with appropriate backup and access controls. Maintain a master log of all received and verified documents for easy retrieval during audits or inspections.

7. Handling Deviations and Escalations

In cases of discrepancies or missing critical documents, initiate corrective actions or escalation to the Regulatory Affairs Head. Document all deviations and resolutions as per quality management system protocols.

8. Periodic Review and Update

See also  SOP for Source Data Verification for Dossier Preparation

Regularly review collected documents to ensure continued validity and update records following regulatory changes or document renewals. Archive superseded documents according to retention policies.

This procedure ensures a robust quality system supporting regulatory compliance, audit readiness, and timely market entry of products across global regions.

Abbreviations

  • GMP – Good Manufacturing Practice
  • RA – Regulatory Affairs
  • SOP – Standard Operating Procedure
  • QA – Quality Assurance
  • DMS – Document Management System

Documents

The following documents are essential for the execution of this SOP:

  1. Country Registration Document Collection Log (Annexure-1)
  2. Document Verification Checklist (Annexure-2)
  3. Discrepancy and Deviation Report Form (Annexure-3)

References

  • ICH Q10: Pharmaceutical Quality System
  • FDA 21 CFR Part 211 – Current Good Manufacturing Practice
  • EU Guidelines for Good Manufacturing Practices
  • WHO Technical Report Series on GMP
  • Internal Quality Manual and Document Control Procedures

Version

1.0

Approval

Prepared By
Checked By
Approved By

Annexures

Annexure-1: Country Registration Document Collection Log

Purpose: To systematically log and track all country registration documents received during the regulatory submission process, ensuring accountability and traceability.

Date Received Country Document Name Document Number Received From Remarks Verified By Verification Date
01/03/2026 USA Drug Registration Certificate US-REG-2026-001 Regulatory Consultant Complete RA Officer 02/03/2026
05/03/2026 Germany Stability Data Report DE-STAB-2026-045 Quality Control Dept. Verified RA Officer 06/03/2026
10/03/2026 Brazil GMP Certificate BR-GMP-2026-022 Manufacturing Unit Pending RA Officer 12/03/2026

Annexure-2: Document Verification Checklist

Purpose: To ensure all collected registration documents meet regulatory and internal compliance standards through a structured verification process.

Document Name Document Number Country Complete (Y/N) Legible (Y/N) Valid Signature/Stamp (Y/N) Version Control Verified (Y/N) Remarks
Drug Registration Certificate US-REG-2026-001 USA Y Y Y Y Approved for submission
Stability Data Report DE-STAB-2026-045 Germany Y Y Y Y Meets requirements
GMP Certificate BR-GMP-2026-022 Brazil N Y N Y Missing signatures; pending correction

Annexure-3: Discrepancy and Deviation Report Form

Purpose: To document and track any discrepancies or deviations identified during document collection or verification for timely resolution.

See also  SOP for Compilation of Regional CMC Variants From Core Dossiers
Report No. Date Document Name Document Number Nature of Discrepancy Action Taken Status Closed By Closure Date
DDR-001 12/03/2026 GMP Certificate BR-GMP-2026-022 Missing authorized signature and stamp Requested re-issue from manufacturing unit Open
DDR-002 15/03/2026 Stability Data Report DE-STAB-2026-045 Discrepancy in batch numbers listed Clarification requested from QC Dept. Closed RA Supervisor 18/03/2026

Revision History

Revision Date Revision No. Revision Details Reason for Revision Approved By
09/04/2026 1.0 Initial issue New SOP creation